Spanish Hospital Coagulation Testing Market 2014
US$ 3,120.00
... contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
390 pages
UK Hospital Coagulation Testing Market 2014
US$ 3,120.00
... Group contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
402 pages
French Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and ...
January 2014
533 pages
German Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and ...
January 2014
530 pages
Italian Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and ...
January 2014
525 pages
Japanese Hospital Tumor Marker Testing Market 2014
US$ 3,880.00
... 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and ...
January 2014
537 pages
Spanish Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and ...
January 2014
521 pages
UK Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, ...
January 2014
527 pages
US Hospital Tumor Marker Testing Market 2014
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market ... , testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and ...
January 2014
567 pages
Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities
US$ 1,920.00
About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Enteric Diseases in France 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Italy 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Japan 2014: Market Outlook and Emerging Opportunities
US$ 2,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...
January 2014
322 pages
Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in the UK 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The ...
January 2014
322 pages
Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities
US$ 3,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The ...
January 2014
322 pages
Respiratory Diseases in France 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
282 pages
Respiratory Diseases in Germany 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
283 pages
Respiratory Diseases in Italy 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
281 pages
Respiratory Diseases in Japan 2014: Market Outlook and Emerging Opportunities
US$ 1,920.00
About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
282 pages
Respiratory Diseases in Spain 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
281 pages
Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test ...
January 2014
281 pages
Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities
US$ 2,880.00
About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test ...
January 2014
283 pages
US Hospital Infectious Disease Testing Market 2014
US$ 5,440.00
This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
January 2014
997 pages
French Hospital Infectious Disease Testing Market 2014
US$ 3,560.00
This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as ...
January 2014
897 pages
German Hospital Infectious Disease Testing Market 2014
US$ 3,560.00
This new report from Venture Planning Group contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as ...
January 2014
897 pages
Italian Hospital Infectious Disease Testing Market 2014
US$ 3,560.00
This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well ...
January 2014
887 pages
Japanese Hospital Infectious Disease Testing Market 2014
US$ 4,640.00
This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, ...
January 2014
891 pages
Spanish Hospital Infectious Disease Testing Market 2014
US$ 3,560.00
This new report from Venture Planning Group contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well ...
January 2014
880 pages
UK Hospital Infectious Disease Testing Market 2014
US$ 3,560.00
This new report from Venture Planning Group contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...
January 2014
886 pages
World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers
US$ 9,200.00
... About this Report This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. ... The report provides test volume and sales forecasts by country and market segment, including: Hospitals Commercial/Private Labs Physician Offices Public ...
January 2014
389 pages
World Respiratory Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Country Forecasts, Strategic Profiles of Key Players
US$ 7,880.00
... About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. ... report provides test volume and sales forecasts by country and market segment, including: Hospitals Commercial/Private Labs Physician Offices Public ...
January 2014
366 pages
World Sexually-Transmitted Disease Testing Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players
US$ 7,680.00
... 200. This new 350-page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The ...
January 2014
350 pages
2014 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents
US$ 6,800.00
This new report from Venture Planning Group provides analyses of current and emerging suppliers of immunodiagnositc, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging ...
January 2014
2014 Leading Agrochemicals Market Players: BASF, Bayer, Dow, DuPont, FMC, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, Syngenta
US$ 3,600.00
... , Monsanto, Nufarm, Sumitomo, and Syngenta. For each company, the report provides: Specific business, new product development and marketing strategies. Strengths and weaknesses. Anticipated acquisitions, joint ventures and divestitures. Major promotional strategies. Distribution approaches. Product ...
January 2014
106 pages
Animal Health Market 2014: Global Trends and Strategies of Key Suppliers
US$ 2,760.00
... trends and strategies of the world's leading animal health companies, including: Five-year forecasts for: Major market segments Key geographic regions ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion ...
January 2014
42 pages
World Animal Health Market Dynamics and Trends 2014
US$ 1,960.00
This new report from Venture Planning Group analyzes marketing strategies of world's leading animal health companies, including: Five-year forecasts for: ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion ...
January 2014
12 pages
2014 Assessments of Major Blood Banking Product Suppliers
US$ 1,960.00
This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, ...
January 2014
50 pages
2014 Leading Diagnostic Imaging Market Players : Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, Toshiba
US$ 3,600.00
... , e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System service and support. Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others. Contains 151 pages
January 2014
151 pages
